IDEXX Laboratories Announces Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Wall St rises as chip stocks' gains offset Middle East jitters
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil eases as investors assess US-Iran peace prospects
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
IDEXX Labs (IDXX) Tops Q2 EPS by 6c, Revenues Beat; Boosts FY18 EPS Outlook
August 1, 2018 6:35 AM EDTIDEXX Labs (NASDAQ: IDXX) reported Q2 EPS of $1.23, $0.06 better than the analyst estimate of $1.17. Revenue for the quarter came in at $580.75 million versus the consensus estimate of $574.55 million.
Reports revenue growth of 14% on a reported basis and 12% on an organic basis, driven by CAG Diagnostics recurring revenue growth of 15% reported and 13% organicAchieves 3,241 premium instrument placements, representing 21% year-over-year growthDelivers EPS of $1.23, a 29% increase year-over-year on a reported basis or 33% on a comparable constant currency basisAdjusts 2018 revenue guidance to $2,205 million $2,230 million, reflecting reported growth of... More